Form 13-F position report

CYTOKINETICS INC COM STK NEW (

Reported by Logos Global Management LP

Company profile Manager portfolio Source filing
CYTK CUSIP 23282W605 Manager CIK 0001792126
Latest reported change

Reported 1,750,000 shares, up 135,000 (8.4%) from the prior quarter.

Reported value 15.7%; share count 8.4% vs. the prior quarter.

Added
% of reported 13F value 12.61% This manager · Q2 2022
Shares 1,750,000 Quarter-end amount reported
Reported value $68,758,000 Fair value at quarter end
Consecutive quarters held 10 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Manager history

Quarterly position history

How this manager's reported quarter-end position changed over time.

18 quarters
Quarter Activity Shares Change % of reported 13F Reported value Filed
Q2 2026 Reduced 0 -875,000 (-100.0%) 0 $0 2026-08-14
Q1 2026 Added 875,000 +575,000 (191.7%) 2.88% $57,671,250 2026-05-15
Q4 2025 New 300,000 +300,000 (0.0%) 1.15% $19,062,000 2026-02-17
Q1 2025 Reduced 0 -900,000 (-100.0%) 0 $0 2025-05-15
Q4 2024 Added 900,000 +500,000 (125.0%) 4.95% $42,336,000 2025-02-14
Q3 2024 New 400,000 +400,000 (0.0%) 2.28% $21,120,000 2024-11-14
Q2 2024 Reduced 0 -100,000 (-100.0%) 0 $0 2024-08-14
Q1 2024 Reduced 100,000 -1,525,000 (-93.8%) 0.57% $7,011,000 2024-05-15
Q4 2023 Added 1,625,000 +375,000 (30.0%) 12.66% $135,671,250 2024-02-14
Q3 2023 Reduced 1,250,000 -400,000 (-24.2%) 4.91% $36,825,000 2023-11-14
Q2 2023 Added 1,650,000 +400,000 (32.0%) 7.32% $53,823,000 2023-08-14
Q1 2023 Reduced 1,250,000 -250,000 (-16.7%) 6.3% $43,987,500 2023-05-15
Q4 2022 Reduced 1,500,000 -200,000 (-11.8%) 8.05% $68,730,000 2023-02-14
Q3 2022 Reduced 1,700,000 -50,000 (-2.9%) 10.13% $82,365,000 2022-11-14
Q2 2022 Added 1,750,000 +135,000 (8.4%) 12.61% $68,758,000 2022-08-15
Q1 2022 Added 1,615,000 +290,000 (21.9%) 7.71% $59,448,000 2022-05-16
Q4 2021 Added 1,325,000 +325,000 (32.5%) 6.23% $60,394,000 2022-02-14
Q3 2021 Reduced 1,000,000 -400,000 (-28.6%) 2.58% $35,740,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history
Institutional context

Who else reported the position

278 managers reported CYTOKINETICS INC COM STK NEW ( for Q2 2022.

Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 13,413,296 +348,678 0.02% $527,008,000 36 qtrs
FMR LLC Added 12,803,824 +97,458 0.05% $503,062,000 36 qtrs
VANGUARD GROUP INC Added 8,960,220 +219,096 < 0.01% $352,047,000 36 qtrs
CITADEL ADVISORS LLC Added 4,642,827 +4,370,177 0.05% $182,416,000 34 qtrs
STATE STREET CORPORATION Added 4,504,226 +307,394 0.01% $176,971,000 37 qtrs
WELLINGTON MANAGEMENT GROUP LLP Added 3,868,632 +2,524,139 0.03% $151,998,000 9 qtrs
Polar Capital Holdings Plc Reduced 3,026,648 -154,652 0.7% $118,917,000 7 qtrs
LORD ABBETT & CO LLC Added 2,990,151 +732,147 0.42% $117,483,000 3 qtrs
RTW INVESTMENTS LP Unchanged 2,561,182 0 2.6% $100,629,000 8 qtrs
PFM Health Sciences LP Unchanged 2,465,016 0 3.69% $96,850,000 7 qtrs
A free account expands this comparison to 25 managers. Create free account
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 15, 2022
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
1,750,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.